Personalized Medicine for Pancreatic Diseases
McGowan Institute for Regenerative Medicine affiliated faculty member David Whitcomb, MD, PhD, the Giant Eagle foundation professor of cancer genetics, chief of gastroenterology, hepatology and nutrition, professor of medicine, cell biology and physiology, and founder and director of the Center for Genomic Sciences, was an invited lecturer hosted by the University of Auckland Department of Surgery in New Zealand. As an internationally respected expert in personalized medicine, Dr. Whitcomb spoke of personalized medicine for pancreatic diseases and how that can be applied as a model for other diseases.
Dr. Whitcomb also participated in a research symposium and established collaborative research links with the Pancreas Research Group led by Professor John Windsor at the University of Auckland.
Dr. Whitcomb specializes in the clinical care and research related to pancreatic diseases, including acute pancreatitis, chronic pancreatitis, pancreatic effects of cystic fibrosis, and pancreatic cancer. He is a pioneer in the integrated use of mathematics, genetics, neurosciences, immunology, epidemiology and clinical sciences to study complex inflammation disorders and cancer risks of the digestive system. His ground-breaking work in developing an effective program for delivering the specific individualized information, especially from genetic profiling, needed for personalized medicine is being studied and emulated by other leading programs throughout the world.
Dr. Whitcomb’s lecture was entitled “Personalized medicine for pancreatic diseases: a breakthrough model for other diseases?”